GENE ONLINE|News &
Opinion
Blog

Multiple Sclerosis
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
TG Notches FDA Victory For CD20 Antibody For Multiple Sclerosis
2022-12-29
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Biogen Strengthens its Grip on the Multiple Sclerosis Market with Another FDA Approval
2021-02-02
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
Sanofi Advances in Multiple Sclerosis Market with Principia Acquisition Deal
2020-08-18
Novartis Wins Five Simultaneous Drug Approvals in Japan
2020-07-06
Novartis Reveals Positive Ofatumumab Data for Treating Relapsing Forms of Multiple sclerosis
2020-06-07
Breakthrough Stem Cell Therapy Research Shows Repair in Multiple Sclerosis Damage
2020-05-24
Novartis Announces Mayzent Data that Shows Extended Benefit in Secondary Progressive MS
2020-04-21
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
LATEST
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
Scroll to Top